HSP90AB1 and cancer: They also test for the first time STA-12-7191 an impermeant inhibitor of Hsp90 derived from ganetespib and show this compound is not only markedly less cytotoxic than ganetespib but it can also inhibit cancer cell migration in a wound healing assay.